CLINICAL_TRIALS
trial_result
· 2011-10-07
Clinical Trial Update: ToleroMune Ragweed Exposure Chamber Study [Phase 2]
Summary
A Phase 2 clinical trial update for ToleroMune in ragweed allergy has completed, using an exposure chamber to assess outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Circassia Limited | Conditions: Ragweed Allergy | Phase 2 | Status: COMPLETED